Zeev's Turnips Patch-No Politics (ZEEV)

[DlphcOracl]

MustBePatient: Regarding FRX.

It does indeed have a P/S and P/B of slightly over 4. However, it has a 37% operating margin, zero long-term debt and DOES have substantial free cash flow, about $700 million per year. What I especially like about FRX is what Zeev alluded to in a response ---- that sentiment toward the pharmaceutical sector is SO negative. This is something Schaeffer's Investment uses to great advantage.

I would have preferred that it form a nice base, but still feel that nibbling with a partial position has substantially more upside than downside at this level.